本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Fulcrum Therapeutics

3.76
-0.0100-0.27%
盤後3.760.00000.00%16:11 EDT
成交量:365.52萬
成交額:1,375.61萬
市值:2.87億
市盈率:-3.11
高:3.81
開:3.77
低:3.76
收:3.77
52周最高:15.74
52周最低:2.83
股本:7,629.73萬
流通股本:6,349.06萬
量比:3.76
換手率:5.76%
股息:- -
股息率:- -
每股收益(TTM):-1.2104
每股收益(LYR):-1.1819
淨資產收益率:-32.38%
總資產收益率:-19.59%
市淨率:0.92
市盈率(LYR):-3.18

資料載入中...

2022/05/10

重要事件披露

8-K - Current report
2022/05/09

重要事件披露

8-K - Current report
2022/05/09

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/03/10

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/03/10

重要事件披露

8-K - Current report
2022/03/09

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/03/03

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/03/03

重要事件披露

8-K - Current report
2022/03/03

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/27

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/01/10

重要事件披露

8-K - Current report
2022/01/04

重要事件披露

8-K - Current report
2021/11/12

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/11/12

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/09/24

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/09/24

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/08/12

重要事件披露

8-K - Current report